08/08/2025 3:34 PM | Aptevo Therapeutics (Issuer) Grant Grady III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2025 3:35 PM | Aptevo Therapeutics (Issuer) Taylor Daphne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2025 3:36 PM | Abdun-Nabi Daniel (Reporting) Aptevo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2025 11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
07/24/2025 4:28 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/09/2025 4:32 PM | Aptevo Therapeutics (Issuer) Huebner Dirk (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/08/2025 1:11 PM | Aptevo Therapeutics (Subject) YA II PN, Ltd. (Filed by)
| Form SCHEDULE 13G | |
07/07/2025 11:11 AM | Aptevo Therapeutics (Filer)
| Form DEF 14A | |
07/03/2025 3:15 PM | Aptevo Therapeutics (Filer)
| Form ARS | |
06/25/2025 3:30 PM | Aptevo Therapeutics (Subject) BIGGER CAPITAL FUND L P (Filed by)
| Form SCHEDULE 13G | |
06/25/2025 3:38 PM | Aptevo Therapeutics (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for APVO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
06/23/2025 4:32 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
06/23/2025 3:05 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2025 3:07 PM | Aptevo Therapeutics (Subject) L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
| Form SCHEDULE 13G/A | |
06/23/2025 3:08 PM | Aptevo Therapeutics (Subject) L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
| Form SCHEDULE 13G | |
06/20/2025 4:15 PM | Aptevo Therapeutics (Filer)
| Form 424B5 | |
06/20/2025 4:21 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2025 8:00 AM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
06/19/2025 11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
06/18/2025 1:30 PM | Aptevo Therapeutics (Filer)
| Form S-1MEF | |
06/16/2025 7:15 AM | Aptevo Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
05/28/2025 3:05 PM | Aptevo Therapeutics (Filer)
| Form 424B3 | |
05/23/2025 4:10 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2025 11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
05/22/2025 4:29 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2025 3:15 PM | Aptevo Therapeutics (Filer)
| Form 424B5 | |
05/15/2025 3:05 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2025 4:30 PM | Aptevo Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
05/13/2025 7:08 AM | Aptevo Therapeutics (Filer)
| Form RW | |
05/13/2025 7:08 AM | Aptevo Therapeutics (Filer)
| Form RW | |
04/29/2025 4:00 PM | Aptevo Therapeutics (Filer)
| Form 424B5 | |
04/28/2025 7:01 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2025 7:15 AM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
04/18/2025 11:22 AM | Aptevo Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
04/10/2025 4:06 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
04/10/2025 9:14 AM | Aptevo Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/09/2025 4:31 PM | Aptevo Therapeutics (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
04/08/2025 7:00 PM | Aptevo Therapeutics (Subject) BIGGER CAPITAL FUND L P (Filed by)
| Form SCHEDULE 13G | |
04/07/2025 3:51 PM | Aptevo Therapeutics (Subject) L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
| Form SCHEDULE 13G | |
04/04/2025 3:15 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2025 9:10 AM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
Alex’s “Next Magnificent Seven” stocks (Ad) The original “Magnificent Seven” turned $7K into $1.18 million.
Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live. Watch the “Next Magnificent Seven” presentation here |
04/01/2025 5:51 AM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/27/2025 4:14 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/27/2025 6:23 AM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/25/2025 5:42 AM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/20/2025 7:44 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/03/2025 5:12 AM | Aptevo Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
02/26/2025 11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
02/14/2025 7:50 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 7:52 AM | Aptevo Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/11/2025 7:37 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/10/2025 5:58 PM | Aptevo Therapeutics (Subject) Hudson Bay Capital Management LP (Filed by)
| Form SCHEDULE 13G/A | |
01/02/2025 11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
12/20/2024 3:30 PM | Aptevo Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/12/2024 4:15 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2024 8:05 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2024 7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/03/2024 4:05 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2024 7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2024 7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 1:57 PM | Aptevo Therapeutics (Subject) Hudson Bay Capital Management LP (Filed by)
| Form SC 13G | |
11/07/2024 7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024 7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 3:30 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 3:48 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
09/18/2024 3:07 PM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/17/2024 4:28 PM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
09/16/2024 11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
09/16/2024 7:09 AM | Aptevo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2024 4:26 PM | Aptevo Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |